Originally founded in 2015 as a result of joint venture between Mayo Clinic and Hillhouse Capital, China’s Huimei Healthcare announced last week that it had closed $30M in Series C funding, led by Qiming Ventures and WuXi AppTech. The funds will be used by the company to develop its core-product, an AI-based Clinical Decision Support System (CDSS) called Dr Mayson, as well as for further product...
